# Pain Prevention and Treatment Through the Enhancement of the Anti-nociceptive Component of Pain Modulation Profiles

> **NCT02020122** · NA · COMPLETED · sponsor: **Rambam Health Care Campus** · enrollment: 5 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Duloxetine
- **DRUG:** Pregabalin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02020122
- **Lead sponsor:** Rambam Health Care Campus
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2017-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02020122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02020122, "Pain Prevention and Treatment Through the Enhancement of the Anti-nociceptive Component of Pain Modulation Profiles". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02020122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*